Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2025-12-25 @ 7:37 PM
Study NCT ID:
NCT06584032
Status:
RECRUITING
Last Update Posted:
2025-01-07
First Post:
2024-08-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
Sponsor:
Hutchmed
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2024-013-00CH1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None